• Sulfo-NHS-LC-Biotin: Protocols for Cell Surface Biotinylatio

  2026-05-23

  Sulfo-NHS-LC-Biotin addresses the need for selective, stable biotin labeling of primary amines on cell surface proteins under aqueous conditions. It should be used when irreversible, membrane-impermeable labeling is required, and is unsuitable for intracellular or reversible biotinylation workflows.

• D-Luciferin Potassium Salt: Pioneering Translational Oncolog

  2026-05-22

  This thought-leadership article examines the mechanistic power and strategic value of D-Luciferin (potassium salt) as a gold-standard substrate for luciferase in translational oncology. By integrating insights from recent mechanistic studies, including the Pin1/BRD4 pathway in hyperglycemia-driven gastric cancer, and juxtaposing competitive product performance, this piece provides actionable guidance for researchers aiming to elevate their in vivo bioluminescence imaging and quantitative assays. It further distinguishes itself by proposing a forward-looking vision rooted in evidence-based translational impact.

• Epalrestat (SKU B1743): Reliable Aldose Reductase Inhibitor

  2026-05-22

  This article provides a scenario-driven guide for biomedical researchers and laboratory teams facing common challenges in cell viability, proliferation, and cytotoxicity assays. By leveraging Epalrestat (SKU B1743), a high-purity aldose reductase inhibitor from APExBIO, the article demonstrates how reproducible, mechanism-driven results can be achieved in oxidative stress, diabetic neuropathy, and cancer metabolism research.

• Polybrene (Hexadimethrine Bromide): Accelerating Viral Trans

  2026-05-21

  Polybrene (Hexadimethrine Bromide) 10 mg/mL transforms lentiviral and retroviral gene delivery by neutralizing cellular charge barriers, and also streamlines lipid-mediated DNA transfection and peptide sequencing workflows. Explore protocol-driven enhancements, troubleshooting insights, and real-world applications that set APExBIO's Polybrene apart in reproducible cell engineering.

• Sodium-Induced Mitochondrial Dysfunction Drives NECSO Cell D

  2026-05-21

  Qiao et al. uncover how sodium influx via TRPM4 channels disrupts mitochondrial energy metabolism, leading to necrosis by sodium overload (NECSO). Their findings clarify the mechanistic link between sodium dysregulation, mitochondrial dysfunction, and cell death, with implications for disease contexts involving Na+ imbalance.

• GSK126 EZH2 Inhibitor: Transforming Pluripotency and Cancer

  2026-05-20

  Discover how the GSK126 EZH2 inhibitor enables breakthroughs in epigenetic regulation, advancing both cancer research and stem cell biology. This article reveals unique insights into PRC2 inhibition and practical assay design.

• Lipid Peroxidation (MDA) Assay Kit: Precision in Ferroptosis

  2026-05-20

  The Lipid Peroxidation (MDA) Assay Kit enables ultra-sensitive, dual-mode detection of malondialdehyde (MDA), powering robust investigations into oxidative stress and ferroptosis mechanisms. This article breaks down best-practice workflows and troubleshooting guidance, spotlighting its unique advantages in translational studies of drug resistance and lipid peroxidation.

• Moxidectin Enhances Polyene Efficacy Against Oral Candida vi

  2026-05-19

  This study uncovers how moxidectin, an antiparasitic agent, boosts ergosterol synthesis in Candida albicans, thereby synergizing with polyene antifungals like amphotericin B and nystatin to combat oral candidiasis. The findings highlight a promising strategy to potentiate existing antifungal therapies, especially in the context of resistance and biofilm-associated infections.

• DAPI Solution: Applied Nuclear Visualization & Apoptosis Det

  2026-05-19

  Harness the robust DNA affinity of DAPI Solution (1 mg/mL) for high-contrast nuclear visualization, precise viability assessment, and apoptosis detection in both microscopy and flow cytometry workflows. This guide translates recent breakthroughs in disc degeneration research into hands-on protocols and advanced troubleshooting tips, empowering reproducible and insightful cellular assays.

• Self-Assembling Virus-Mimicking Particles for Extrahepatic m

  2026-05-18

  This study introduces a modular, biomimetic platform for delivering mRNA to extrahepatic organs, addressing the limitations of hepatic tropism in conventional delivery systems. Using engineered enveloped virus-mimicking particles (EVMPs), the researchers achieved efficient, safe, and targeted mRNA delivery—demonstrated with IL-12 mRNA in a metastatic lung tumor model—broadening the potential of mRNA-based immunotherapy.

• miR-196a Drives Esophageal Cancer Aggressiveness via MYC/TER

  2026-05-18

  This study uncovers how microRNA 196a (miR-196a) promotes the aggressiveness of esophageal adenocarcinoma by orchestrating a signaling cascade involving c-MYC, TERT, and NFκB. The findings highlight the pivotal role of the c-MYC/TERT/NFκB axis in epithelial-to-mesenchymal transition and tumor progression, offering a mechanistic basis for targeted cancer research.

• Estradiol-ERα Modulation of T Cell Recovery After Hemorrhagi

  2026-05-17

  This study reveals that 17β-estradiol restores splenic CD4+ T lymphocyte function after hemorrhagic shock by suppressing endoplasmic reticulum stress (ERS) via the ERα and GPR30 pathways, but not ERβ. The findings clarify receptor subtype roles in immune regulation post-trauma, with implications for endocrine and immunological research.

• Minocycline HCl in Microglial Modulation: Insights for Retin

  2026-05-16

  Explore how Minocycline HCl, a semisynthetic tetracycline antibiotic, specifically modulates microglial activity and MHC-II pathways in retinal models, advancing our understanding of inflammation and neurodegeneration. This article uniquely connects mechanistic insights with practical assay design, providing actionable guidance for researchers.

• Everolimus (RAD001): Strategic mTOR Inhibition for Translati

  2026-05-15

  This article provides translational researchers with a mechanistic and strategic guide to Everolimus (RAD001), integrating recent advances in in vitro drug response assessment, actionable protocol parameters, and outlooks for cancer biology. By linking evidence-based insights with workflow best practices, we help research teams maximize the translational impact of mTOR pathway inhibition.

• Frizzled5 Links Cholesterol Metabolism to Wnt/β-Catenin in C

  2026-05-15

  This study uncovers a unique mechanism by which Frizzled5, a Wnt receptor, directly senses cholesterol via its extracellular linker region, driving pancreatic cancer growth through Wnt/β-catenin signaling. The findings provide a new molecular connection between aberrant cholesterol metabolism and oncogenic signaling, opening avenues for targeted intervention in Wnt-dependent cancers.

464 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page